Skip to content
Try Mental Wellness – Lifestyle
Author:
XORTX Therapeutics Inc.
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
←
Previous Page
1
2